cTfRMAb-ASA fusion protein (ArmaGen Technologies)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NamecTfRMAb-ASA fusion protein (ArmaGen Technologies)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionArylsulfatases stimulants

TargetsArylsulfatases

Therapy Area/IndicationsLeukodystrophy, Metachromatic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesArmagen Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesArmagen Inc

Active IndicationsN/A

Inactive IndicationsLeukodystrophy, Metachromatic

Other Information

ATC CodeN/A